oral HRT in aPL-negative women with SLE who have stable low-level disease activity and no contraindication to use aPL-positive patients. Estrogen use in aPL-positive patients should be avoided due to the potential increased risk of thrombosis. Data are limited, however, for many clinical situations, and specific recommendations vary in strength for this reason. In women with asymptomatic aPL, we conditionally recommend against treating with HRT. We strongly recommend against use of HRT in women